<?xml version="1.0" encoding="UTF-8"?>
<p id="Par4">Although attempts have been made to standardize the clinical and therapeutic approach to infective complications in immunocompromised hematological patients, the clinical expression of infections is extremely variable. The continuous changes in the epidemiology of infections, clinical manifestations of hematological patients and available therapies imply a lack of an uniform consensus on the best management of infective complications and the need for continuous updates [
 <xref ref-type="bibr" rid="CR3">3</xref>]. Besides, the optimal approach to infective complications often needs to be personalized.
</p>
